These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 18200609

  • 1. Early behavioural changes during antidepressant treatment in elderly patients.
    Kok RM, Vink D, Westers P, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):769-71. PubMed ID: 18200609
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [Abstract] [Full Text] [Related]

  • 3. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U, Wendt G.
    Fortschr Med; 1982 Dec 02; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract] [Full Text] [Related]

  • 4. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A.
    Mol Interv; 2002 Apr 02; 2(2):72-6. PubMed ID: 14993352
    [No Abstract] [Full Text] [Related]

  • 5. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B, Grünberger J.
    Adv Biochem Psychopharmacol; 1982 Apr 02; 32():175-80. PubMed ID: 7046363
    [No Abstract] [Full Text] [Related]

  • 6. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A.
    Adv Biochem Psychopharmacol; 1982 Apr 02; 32():43-7. PubMed ID: 7046367
    [No Abstract] [Full Text] [Related]

  • 7. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL, Wakelin JS, Calanca A, Hole G.
    Adv Biochem Psychopharmacol; 1982 Apr 02; 32():69-75. PubMed ID: 7046368
    [No Abstract] [Full Text] [Related]

  • 8. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G, Galzenati M, Balbi A.
    Adv Biochem Psychopharmacol; 1982 Apr 02; 32():151-6. PubMed ID: 7046362
    [No Abstract] [Full Text] [Related]

  • 9. Clinical profile of the novel antidepressant bupropion.
    Stern WC, Harto-Truax N, Rogers J, Miller L.
    Adv Biochem Psychopharmacol; 1982 Apr 02; 32():21-34. PubMed ID: 6807060
    [No Abstract] [Full Text] [Related]

  • 10. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP.
    Psychopharmacol Bull; 1986 Apr 02; 22(1):186-91. PubMed ID: 3523576
    [No Abstract] [Full Text] [Related]

  • 11. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R, Ziegenhorn A, Heuser I, Deuschle M.
    Pharmacopsychiatry; 2008 Mar 02; 41(2):66-71. PubMed ID: 18311687
    [Abstract] [Full Text] [Related]

  • 12. Trazodone in the treatment of psychoneuroses: a double-blind study.
    Antonelli F, De Gregorio M, Dionisio A.
    Curr Ther Res Clin Exp; 1973 Oct 02; 15(10):799-804. PubMed ID: 4201978
    [No Abstract] [Full Text] [Related]

  • 13. [Long-term treatment of patients in neurological practices with antidepressive agents].
    Schüssler G, Linden M, Müller-Oerlinghausen B.
    Nervenarzt; 1984 Mar 02; 55(3):137-42. PubMed ID: 6425705
    [No Abstract] [Full Text] [Related]

  • 14. Generalizability of antidepressant efficacy trials.
    Zimmerman M, Posternak MA, Chelminski I.
    Essent Psychopharmacol; 2004 Mar 02; 6(1):45-58. PubMed ID: 15612653
    [No Abstract] [Full Text] [Related]

  • 15. Antidepressant mythology.
    Jensen D, Joyce PR.
    N Z Med J; 1989 Jun 14; 102(869):288-90. PubMed ID: 2660030
    [No Abstract] [Full Text] [Related]

  • 16. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder.
    Tondo L, Lepri B, Baldessarini RJ.
    Acta Psychiatr Scand; 2008 Aug 14; 118(2):106-15. PubMed ID: 18397362
    [Abstract] [Full Text] [Related]

  • 17. First results of an open phase II study with the antidepressant paroxetine.
    Stuppäck C, Schubert H, Barnas C, Mair M, Schifferle I, Unterweger B, Wömhart L, Fleischhacker WW, Hinterhuber H.
    Pharmacopsychiatry; 1988 Nov 14; 21(6):369-70. PubMed ID: 2977442
    [No Abstract] [Full Text] [Related]

  • 18. A quantitative analysis of clinical drug trials for the treatment of affective disorders.
    Davis JM, Wang Z, Janicak PG.
    Psychopharmacol Bull; 1993 Nov 14; 29(2):175-81. PubMed ID: 8290662
    [Abstract] [Full Text] [Related]

  • 19. The diagnosis and treatment of depression in the geriatric population.
    Khouzam HR.
    Compr Ther; 2009 Nov 14; 35(2):103-14. PubMed ID: 19618759
    [Abstract] [Full Text] [Related]

  • 20. Drug treatment of depression in general practice.
    Wheatley D, Little JC.
    Practitioner; 1982 Feb 14; 226(1364):316-20. PubMed ID: 7088828
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.